| # | Drug | Count |
|---|---|---|
| 0 | TACROLIMUS | 17 |
| 1 | MYCOPHENOLATE MOFETIL | 16 |
| 2 | TACROLIMUS EXTENDED-RELEASE CAPSULES | 15 |
| 3 | TACROLIMUS OINTMENT 0.1% | 15 |
| 4 | DARBEPOETIN ALFA | 14 |
| 5 | METHYLPREDNISOLONE | 13 |
| 6 | RITUXIMAB | 8 |
| 7 | CARBOPLATIN | 7 |
| 8 | PACLITAXEL | 7 |
| 9 | VALGANCICLOVIR | 7 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | DIMETICONE | 1 | 0.0035 |
| 1 | SEVELAMER HYDROCHLORIDE | 2 | 0.0035 |
| 2 | DIFELIKEFALIN | 1 | 0.0024 |
| 3 | QUIZARTINIB | 1 | 0.0014 |
| 4 | ETELCALCETIDE | 4 | 0.0014 |
| 5 | PASIREOTIDE | 2 | 0.0009 |
| 6 | LANTHANUM CARBONATE | 3 | 0.0006 |
| 7 | OMEGA-3-ACID ETHYL ESTERS | 1 | 0.0005 |
| 8 | UREA | 1 | 0.0005 |
| 9 | TOLVAPTAN | 6 | 0.0004 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Vasopressin V2 Receptor Antagonist [EPC] | 6 | 0.0004 |
| 1 | Lipid-based Polyene Antifungal [EPC] | 5 | 0.0004 |
| 2 | Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] | 7 | 0.0003 |
| 3 | Somatostatin Analog [EPC] | 2 | 0.0003 |
| 4 | Erythropoiesis-stimulating Agent [EPC] | 14 | 0.0003 |
| 5 | beta Lactamase Inhibitor [EPC] | 1 | 0.0002 |
| 6 | CD38-directed Cytolytic Antibody [EPC] | 1 | 0.0002 |
| 7 | Vitamin D3 Analog [EPC] | 3 | 0.0001 |
| 8 | Antimetabolite Immunosuppressant [EPC] | 3 | 0.0001 |
| 9 | Polyene Antifungal [EPC] | 5 | 0.0001 |